Akari Therapeutics Plc (AKTX)
11.63
+0.79
(+7.29%)
USD |
NASDAQ |
Sep 04, 16:00
11.63
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.382M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.3791M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.3791M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 9.991M |
| March 31, 2017 | -0.0056M |
| December 31, 2016 | 35.13M |
| September 30, 2016 | 1.019M |
| June 30, 2016 | -46.13M |
| March 31, 2016 | -0.0399M |
| December 31, 2015 | -0.0098M |
| September 30, 2015 | 1.401M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DBV Technologies SA | -0.5998M |
| Cellectis SA | 18.75M |
| argenx SE | -- |
| Autolus Therapeutics Plc | 68.03M |
| Evaxion AS | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.112M |
| Cash from Financing (Quarterly) | 8.034M |
| Free Cash Flow | -10.74M |
| Free Cash Flow Per Share (Quarterly) | -1.737 |
| Free Cash Flow to Equity (Quarterly) | -3.073M |
| Free Cash Flow to Firm (Quarterly) | -3.032M |
| Free Cash Flow Yield | -67.67% |